Comparison of the Xpert breast cancer stratifier mRNA assay with central ER, PR, HER2, and Ki67 immunohistochemistry (IHC) for rapid biomarker analysis in developing countries

被引：0
|
作者：
Brock, J. E.
Milner, D. A.
Ho, K.
Natalie, W.
Victor, C.
Annaliza, R.
Teresa, B.
Kathryn, G-F
Edwin, L. W.
Jodi, W.
Wendy, W.
Michael, B.
机构：
[1] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[2] Cepheid, Sunnyvale, CA USA
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.SABCS16-P2-05-07
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2-05-07
引用
收藏
页数：2
相关论文
共 50 条
  • [1] High concordance of ER, PR, HER2 and Ki67 by central IHC and FISH with mRNA measurements by GeneXper® breast cancer stratifier assay
    Wu, N. C.
    Wong, W.
    Ho, K. E.
    Chu, V. C.
    Rizo, A.
    Davonport, S.
    Kelly, D.
    Makar, R.
    Jassem, J.
    Duchnowska, R.
    Biernat, W.
    Radecka, B.
    Fujita, T.
    Klein, J. L.
    Stonecypher, M.
    Ohta, S.
    Juhl, H.
    Weidler, J. M.
    Bates, M.
    Press, M. F.
    CANCER RESEARCH, 2017, 77
  • [2] Comparing the Gene Xpert Breast Cancer RUO mRNA Assay with ER and HER2 Immunohistochemistry (IHC) for Rapid Biomarker Analysis
    Mugabe, Marcellin
    Andrici, Juliana
    Ho, Ken
    Wu, Natalie
    Rizo, Annnaliza
    Lai, Edwin W.
    Jodi, Weidler
    Wendy, Wong
    Bates, Michael
    Izimukwiye, Isabelle
    Muvunyi, Jean Baptiste
    Rugwizangoga, Belson
    Milner, Danny A.
    Brock, Jane
    MODERN PATHOLOGY, 2017, 30 : 60A - 60A
  • [3] Comparing the Gene Xpert Breast Cancer RUO mRNA Assay with ER and HER2 Immunohistochemistry (IHC) for Rapid Biomarker Analysis
    Mugabe, Marcellin
    Andrici, Juliana
    Ho, Ken
    Wu, Natalie
    Rizo, Annnaliza
    Lai, Edwin W.
    Jodi, Weidler
    Wendy, Wong
    Bates, Michael
    Izimukwiye, Isabelle
    Muvunyi, Jean Baptiste
    Rugwizangoga, Belson
    Milner, Danny A.
    Brock, Jane
    LABORATORY INVESTIGATION, 2017, 97 : 60A - 60A
  • [4] Comparison of ER, PR, HER2 and Ki67 expression by MammaTyper® RT-qPCR and immunohistochemistry (IHC) on needle core biopsies of breast cancer
    Shaaban, A.
    Badr, N.
    Zaakouk, M.
    Kearns, D.
    Kong, A.
    EUROPEAN JOURNAL OF CANCER, 2022, 175 : S87 - S88
  • [5] Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer
    Lili Chen
    Yanyang Chen
    Zhongpeng Xie
    Jiao Luo
    Yuefeng Wang
    Jianwen Zhou
    Leilei Huang
    Hongxia Li
    Linhai Wang
    Pei Liu
    Man Shu
    Wenhui Zhang
    Zunfu Ke
    Breast Cancer Research and Treatment, 2022, 194 : 517 - 529
  • [6] Comparison of immunohistochemistry and RT-qPCR for assessing ER, PR, HER2, and Ki67 and evaluating subtypes in patients with breast cancer
    Chen, Lili
    Chen, Yanyang
    Xie, Zhongpeng
    Luo, Jiao
    Wang, Yuefeng
    Zhou, Jianwen
    Huang, Leilei
    Li, Hongxia
    Wang, Linhai
    Liu, Pei
    Shu, Man
    Zhang, Wenhui
    Ke, Zunfu
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 194 (03) : 517 - 529
  • [7] mRNA expression of ER, PR, HER2 and Ki67 are concordant to central ihc and predict clinical outcome: A validation study from the ABCSG-6 biomarker cohort
    Filipits, M.
    Rudas, M.
    Singer, C.
    Bago-Horvath, Z.
    Greil, R.
    Balic, M.
    Lax, S. F.
    Wu, N.
    Zhao, S.
    Weidler, J.
    Bates, M.
    Hlauschek, D.
    Gnant, M.
    Dubsky, P.
    ANNALS OF ONCOLOGY, 2018, 29 : 480 - 480
  • [8] Clinical assessment of immunohistochemistry, digital image quantification and AQUA for breast biomarkers ER, PR, HER2 and Ki67
    Gandy, M.
    Stone, K.
    Allen, D.
    Jones, P.
    Miller, K.
    Hamoudi, R.
    Falzon, M.
    Wells, C.
    VIRCHOWS ARCHIV, 2014, 465 : S114 - S114
  • [9] Validation of the 'APIS Breast Cancer Subtyping Kit' mRNA assay to test for ER, PR, HER-2, and Ki67 in Invasive Breast Cancer
    Simonovic, A., V
    Collins, N.
    Costa, D.
    Faulkes, C.
    Kobutungi, B.
    Kolio, P.
    Paterson, F.
    Horsnell, J.
    Pakzad, F.
    Irvine, T.
    Partlett, P.
    Clayton, E.
    Di Palma, S.
    JOURNAL OF PATHOLOGY, 2024, 264 : S21 - S21
  • [10] The Correlation of Nottingham Prognostic Index with Immunoexpression of ER, PR, HER2, and Ki67 in Breast Cancer Tissue
    Ruangpratheep, Chetana
    Piyaisrakul, Supakorn
    ANNALS OF ONCOLOGY, 2019, 30 : 93 - 93
12345